Categories: Automobile

30 km/h Direct Impact Against 242 mm-high Obstacle: TIGGO7 CSH Passes Mexico Battery Scrape Test Without Critical Damage

MEXICO CITY, July 30, 2025 /PRNewswire/ — On July 29, Chery’s flagship model TIGGO7 CSH successfully completed an extreme battery scrape test. Witnessed by Mr. Isac Mosqueda Montelongo, Representative of Notary Public 167 of Mexico City, industry experts and leading media representatives, the SUV struck a 242 mm-high spherical barrier at 30 km/h with 30mm of overlap depth—replicating dangerous high-altitude road scrape scenarios.

- Advertisement -

TIGGO7 CSH demonstrated outstanding battery protection capabilities following the severe impact, with only minor surface scratches visible on the battery casing and no signs of electrolyte leakage, fire, explosion, or smoke. The battery pack maintained excellent structural integrity, showing minimal bottom deformation while all high-voltage connectors remained fully operational.

- Advertisement -

The test conclusively validated the robust capabilities of Chery’s “Guardian Battery” system. Its lithium iron phosphate blade battery provides an inherently stable chemical foundation, while the 780MPa high-strength steel underbody armor —combined with a chainmail-inspired structural design—effectively dissipates impact forces. The system’s millisecond-response high-voltage cutoff technology (disconnecting circuits within 10ms) eliminates short-circuit risks, and its IP68-rated dustproof certification ensures reliable performance under the most challenging road conditions.

- Advertisement -

The Mexico battery scrape test marks the third stop of Chery Super Hybrid (CSH)’s global safety challenge tour, following rigorous evaluations in China including spiral rollover and dual-vehicle collision test, along with a grueling 53-hour saltwater immersion trial in Indonesia. Chery continues to validate its vehicles under six extreme global conditions—extreme cold, extreme heat, extreme dryness, extreme humidity, high-speed conditions, and rough terrain—positioning itself as the first Chinese automaker to conduct comprehensive extreme safety validation overseas. The automaker further amplifies its safety commitment through high-visibility displays at Dubai International Airport, the world’s busiest international travel hub, proclaiming its core safety philosophy: “Safety, for Family.” Leveraging its industry-leading battery safety technology, Chery is accelerating its global hybrid market expansion, turning its vision of “Let everyone enjoy five-star protection” into a tangible reality for customers worldwide.

- Advertisement -

Photo – https://mma.prnewswire.com/media/2741095/TIGGO7_CSH.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/30-kmh-direct-impact-against-242-mm-high-obstacle-tiggo7-csh-passes-mexico-battery-scrape-test-without-critical-damage-302517450.html

- Advertisement -
PRNW Agency

Recent Posts

ProFrac Holding Corp. Reports Third Quarter 2025 Results

WILLOW PARK, Texas--(BUSINESS WIRE)--ProFrac Holding Corp. (NASDAQ: ACDC) (“ProFrac”, or the “Company”) today announced financial…

1 hour ago

Palabra AI Acquires Talo and Launches Suite of Real-Time Multilingual Communication Products

LONDON--(BUSINESS WIRE)--Palabra AI, the company behind sub-second speech-to-speech translation, today announced the acquisition of Talo…

1 hour ago

FPT APPOINTS ABES AS ITS FIRST DISTRIBUTOR IN INDIA TO EXPAND ITS MARKET PRESENCE

TURIN, Italy, Nov. 10, 2025 /PRNewswire/ -- FPT, the Iveco Group brand dedicated to the design, production,…

1 hour ago

Torch Relay for the 15th National Games Kicks Off, with Feng Xingya, Chairman and President of GAC Group, Serving as Torchbearer

HONG KONG, Nov. 2, 2025 /PRNewswire/ -- On November 2, the torch relay for the…

1 hour ago

GENFIT Enters Research Collaboration with EVerZom to Advance Exosome-based Regenerative Technology in ACLF

EVerZom’s investigational drug candidate EViv, developed to treat ACLF, using its proprietary exosome platform, represents…

4 hours ago

GENFIT Presents Promising New Preclinical Data on NTZ/G1090N for the Treatment of ACLF at The Liver Meeting 2025

Preclinical studies demonstrated significant efficacy on systemic inflammation and organ function in ACLF disease modelsSafety…

4 hours ago